Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.936 |
High Similarity |
NPD3027 |
Phase 3 |
0.875 |
High Similarity |
NPD5283 |
Phase 1 |
0.8583 |
High Similarity |
NPD228 |
Approved |
0.8561 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8561 |
High Similarity |
NPD1613 |
Approved |
0.8417 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8417 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8397 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8295 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8045 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7985 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7939 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.791 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7886 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7883 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7883 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7879 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7868 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7863 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7801 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7769 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7754 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7752 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD37 |
Approved |
0.7667 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7612 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7609 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7597 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7589 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7589 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7586 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7569 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7569 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7557 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7556 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7554 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7552 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7537 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7537 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7537 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7536 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7536 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD4965 |
Approved |
0.75 |
Intermediate Similarity |
NPD2801 |
Approved |
0.75 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2977 |
Approved |
0.75 |
Intermediate Similarity |
NPD2978 |
Approved |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7482 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7463 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7447 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7445 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7444 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7444 |
Intermediate Similarity |
NPD5846 |
Approved |
0.744 |
Intermediate Similarity |
NPD968 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7421 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7415 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7413 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7413 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7405 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.74 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7397 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7397 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7383 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD290 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7343 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7343 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7333 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7329 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7325 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7324 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7319 |
Intermediate Similarity |
NPD4624 |
Approved |
0.731 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD5762 |
Approved |
0.731 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD52 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7266 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7258 |
Intermediate Similarity |
NPD291 |
Approved |
0.7254 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7254 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7254 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7239 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7226 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7185 |
Intermediate Similarity |
NPD9384 |
Approved |
0.7185 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7185 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7183 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7177 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7174 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7174 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7174 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3686 |
Approved |
0.717 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD3091 |
Approved |
0.716 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5314 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7132 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7132 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7115 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7114 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7113 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7111 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7101 |
Intermediate Similarity |
NPD9622 |
Approved |
0.7101 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7083 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD27 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7078 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD17 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7055
|
Intermediate Similarity |
NPD5844 |
Phase 1 |